Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study - PubMed (original) (raw)
Comparative Study
doi: 10.1111/all.12602. Epub 2015 Mar 16.
Affiliations
- PMID: 25727950
- DOI: 10.1111/all.12602
Comparative Study
Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study
Y-C Chen et al. Allergy. 2015 May.
Abstract
Background: Sequential human herpes virus (HHV) reactivation is well known in drug reaction with eosinophilia and systemic symptom (DRESS), but such a phenomenon has seldom studied in other types of cutaneous adverse drug reactions (cADRs). Moreover, the association between viral reactivations and cytokine or chemokine changes is largely unknown. We aimed to evaluate the viral reactivation rates of HHV-6, HHV-7, Epstein-Barr virus (EBV), and cytomegalovirus (CMV) in different cADRs and their impacts on clinical prognosis. Cytokine and chemokine changes with viral reactivations were also examined.
Methods: A prospective study was conducted to monitor the viral statuses of patients with different cADRs by polymerase chain reaction and serum-specific antibody titers. Changes in plasma cytokine and chemokine levels were also evaluated by sequential blood samples.
Results: Among the various cADRs, HHV-6 reactivation was only observed in DRESS, but EBV and CMV could be detected in other cADRs. Many proinflammatory cytokines and chemokines, including interleukin (IL)-1β, IL-2, IL-6, interferon-γ, tumor necrosis factor-α, were significantly lower in DRESS patients with HHV-6 reactivation when compared to those without HHV-6 reactivation. In addition, these mediators were significantly lower before and during HHV-6 reactivation, compared to cytokine levels after HHV-6 reactivation in the same patient.
Conclusion: HHV-6 reactivation was only observed in DRESS patients, not in any other cADR. In DRESS patients, some proinflammatory cytokines were significantly lower before or during HHV-6 reactivation.
Keywords: Epstein-Barr virus; adverse drug reactions; human herpes virus-6; proinflammatory cytokines; viral reactivation.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
- Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS).
Descamps V, Avenel-Audran M, Valeyrie-Allanore L, Bensaid B, Barbaud A, Al Jawhari M, Ranger-Rogez S; French Study Group of Cutaneous Drug Adverse Reactions. Descamps V, et al. JAMA Dermatol. 2013 May;149(5):565-9. doi: 10.1001/jamadermatol.2013.2018. JAMA Dermatol. 2013. PMID: 23426332 - Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Seishima M, et al. Br J Dermatol. 2006 Aug;155(2):344-9. doi: 10.1111/j.1365-2133.2006.07332.x. Br J Dermatol. 2006. PMID: 16882173 - Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Tohyama M, Hashimoto K, Oda F, Namba C, Sayama K. Tohyama M, et al. J Dermatol. 2020 May;47(5):476-482. doi: 10.1111/1346-8138.15294. Epub 2020 Mar 11. J Dermatol. 2020. PMID: 32162382 Free PMC article. - Serological evidence that activation of ubiquitous human herpesvirus-6 (HHV-6) plays a role in chronic idiopathic/spontaneous urticaria (CIU).
Dreyfus DH. Dreyfus DH. Clin Exp Immunol. 2016 Feb;183(2):230-8. doi: 10.1111/cei.12704. Epub 2015 Nov 24. Clin Exp Immunol. 2016. PMID: 26361716 Free PMC article. Review. - Herpesviruses and the microbiome.
Dreyfus DH. Dreyfus DH. J Allergy Clin Immunol. 2013 Dec;132(6):1278-86. doi: 10.1016/j.jaci.2013.02.039. Epub 2013 Apr 20. J Allergy Clin Immunol. 2013. PMID: 23611298 Review.
Cited by
- The Association of HHV-6 and the TNF-α (-308G/A) Promotor with Major Depressive Disorder Patients and Healthy Controls in Thailand.
Sumala S, Ekalaksananan T, Pientong C, Buddhisa S, Passorn S, Duangjit S, Janyakhantikul S, Suktus A, Bumrungthai S. Sumala S, et al. Viruses. 2023 Sep 8;15(9):1898. doi: 10.3390/v15091898. Viruses. 2023. PMID: 37766304 Free PMC article. - Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review.
Chen CB, Hung WK, Wang CW, Lee CC, Hung SI, Chung WH. Chen CB, et al. Front Med (Lausanne). 2023 Jun 29;10:1187937. doi: 10.3389/fmed.2023.1187937. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37457584 Free PMC article. Review. - Immunopathogenic Insights on Preferential Human Herpesvirus-6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms: A Scoping Review.
Zhu H, Ren V. Zhu H, et al. J Cutan Med Surg. 2023 Jul-Aug;27(4):388-398. doi: 10.1177/12034754231177590. Epub 2023 May 25. J Cutan Med Surg. 2023. PMID: 37231539 Free PMC article. Review. - Successful management with ganciclovir of drug reaction with eosinophilia and systemic symptoms secondary to antituberculous drugs associated to human herpesvirus-6 reactivation.
Corona-Rodarte E, Torres-Guillen VM, Teran-De-la-Sancha K, Barrera-Godínez A, Gatica-Torres M. Corona-Rodarte E, et al. JAAD Case Rep. 2023 Jan 26;34:90-93. doi: 10.1016/j.jdcr.2022.12.021. eCollection 2023 Apr. JAAD Case Rep. 2023. PMID: 37009031 Free PMC article. No abstract available. - Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses.
Ramirez GA, Ripa M, Burastero S, Benanti G, Bagnasco D, Nannipieri S, Monardo R, Ponta G, Asperti C, Cilona MB, Castagna A, Dagna L, Yacoub MR. Ramirez GA, et al. Microorganisms. 2023 Jan 30;11(2):346. doi: 10.3390/microorganisms11020346. Microorganisms. 2023. PMID: 36838310 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources